Literature DB >> 17322927

Non-heartbeating donation of kidneys for transplantation.

Gauke Kootstra1, Ernest van Heurn.   

Abstract

There is a persistent shortage of kidneys available for transplantation. In the early 1980s, therefore, we published the concept of non-heartbeating (NHB) donation; that is, procurement of kidneys from donors whose death has been accompanied by irreversible circulatory arrest. NHB donors are generally categorized using four definitions; category III (awaiting cardiac arrest) and category IV (cardiac arrest while braindead)--or 'controlled'--donors are the most suitable for initiating NHB donation programs. Delayed graft function is associated with use of kidneys from such donors, but has no effect on graft survival in the short or long term. Use of kidneys from category I (dead upon arrival at hospital) and category II (unsuccessfully resuscitated), or 'uncontrolled', donors is likewise associated with delayed graft function, but also with an increased risk of primary nonfunction. Viability testing of donated organs from these sources is a prerequisite for transplantation. Machine preservation parameters and enzyme release measurements help to distinguish viable from nonviable kidneys. The proportion of NHB donor kidneys in the total pool of postmortem kidneys differs considerably between countries. In The Netherlands, the proportion is nearly 50%. This figure is markedly higher than that in the US and Canada, where national programs have now been initiated to increase rates of NHB donation. In the future, warm preservation techniques might facilitate better viability testing, thereby increasing NHB donation from category I and II donors and further reducing the shortage of kidneys available for transplantation.

Entities:  

Mesh:

Year:  2007        PMID: 17322927     DOI: 10.1038/ncpneph0426

Source DB:  PubMed          Journal:  Nat Clin Pract Nephrol        ISSN: 1745-8323


  7 in total

1.  Machine perfusion versus cold storage of livers: a meta-analysis.

Authors:  Sushun Liu; Qing Pang; Jingyao Zhang; Mimi Zhai; Sinan Liu; Chang Liu
Journal:  Front Med       Date:  2016-12-23       Impact factor: 4.592

2.  In vitro and In vivo assessment of a novel organ perfusion stent for successful flow separation in donation after cardiac death.

Authors:  Moataz Elsisy; Bryan Tillman; Lynn Chau; Catherine Go; Sung Kwon Cho; Youngjae Chun
Journal:  J Biomater Appl       Date:  2022-04-25       Impact factor: 2.712

3.  Dual chamber stent prevents organ malperfusion in a model of donation after cardiac death.

Authors:  Bryan W Tillman; Youngjae Chun; Sung Kwon Cho; Yanfei Chen; Nathan Liang; Timothy Maul; Anthony Demetris; Xinzhu Gu; William R Wagner; Amit D Tevar
Journal:  Surgery       Date:  2016-08-11       Impact factor: 3.982

4.  The use of personalized medicine for patient selection for renal transplantation: physicians' views on the clinical and ethical implications.

Authors:  Marianne Dion-Labrie; Marie-Chantal Fortin; Marie-Josée Hébert; Hubert Doucet
Journal:  BMC Med Ethics       Date:  2010-04-09       Impact factor: 2.652

5.  Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survival.

Authors:  A G Lewis; G Köhl; Q Ma; P Devarajan; J Köhl
Journal:  Clin Exp Immunol       Date:  2008-05-26       Impact factor: 4.330

Review 6.  Kidney transplantation and donation in children.

Authors:  Ernest van Heurn; Eva E de Vries
Journal:  Pediatr Surg Int       Date:  2009-03-29       Impact factor: 1.827

7.  Machine perfusion versus cold storage of kidneys derived from donation after cardiac death: a meta-analysis.

Authors:  Ronghai Deng; Guangxiang Gu; Dongping Wang; Qiang Tai; Linwei Wu; Weiqiang Ju; Xiaofeng Zhu; Zhiyong Guo; Xiaoshun He
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.